Unknown

Dataset Information

Hepatitis B screening before chemotherapy: a survey of practitioners' knowledge, beliefs, and screening practices.


ABSTRACT:

Purpose

Hepatitis B virus (HBV) reactivation is a potentially fatal complication of chemotherapy that can be largely prevented with medication, provided that asymptomatic HBV carriers are identified. We explored the knowledge, beliefs, and practices of Canadian oncologists/hematologists regarding HBV screening before chemotherapy.

Methods

A novel questionnaire was mailed to all practicing hematologists/oncologists, where publicly accessible online physician registries facilitated identification of these specialists (71% of the Canadian physician population).

Results

Of 504 potentially eligible practitioners, 311 (62%) responded, of whom 246 indicated that they administered chemotherapy and were thus included in final analyses. Respondents tended to underestimate the r

SUBMITTER: Lee RS 

PROVIDER: S-EPMC3500474 | biostudies-literature | 2012 Nov

REPOSITORIES: biostudies-literature